A B-1a cell subset induces Foxp3-T cells with regulatory activity through an IL-10-independent pathway

Cellular and Molecular Immunology

Volumn 12, Issue 3, 2015, Pages 354-365

  Hsu, Ling Hui ^a   Li, Kun Po ^a   Chu, Kuan Hua ^a   Chiang, Bor Luen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

B 1a cells; IL 10; induction; suppression; Treg cells

Indexed keywords

CD134 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; ICOS PROTEIN, MOUSE; INDUCIBLE T CELL COSTIMULATOR; PDCD1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; B 1A LYMPHOCYTE; B 2 LYMPHOCYTE; B LYMPHOCYTE; CD4+ CD25- T LYMPHOCYTE; CELL CONTACT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FOXP3- T LYMPHOCYTE; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE OF B1A LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; CELL JUNCTION; CELL LINEAGE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PARACRINE SIGNALING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

MUS;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES, REGULATORY; CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERCELLULAR JUNCTIONS; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PARACRINE COMMUNICATION; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84928898586     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.56     Document Type: Article

References (41)

1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787.
2. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012; 30: 221-241.
3. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008; 224: 201-214.
4. Hussain S, Delovitch TL. Intravenous transfusion of BCR-Activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol 2007; 179: 7225-7232.
5. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219-230.
6. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197: 489-501.
7. Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol 2010; 48: 1-8.
8. Tu W, Lau YL, Zheng J, Liu Y, Chan PL, Mao H et al. Efficient generation of human alloantigen-specific CD41 regulatory T cells from naive precursors by CD40-Activated B cells. Blood 2008; 112: 2554-2562.
9. Reichardt P, Dornbach B, Rong S, Beissert S, Gueler F, Loser K et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007; 110: 1519-1529.
10. Amu S, Saunders SP, KronenbergM, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010; 125: 1114-1124.e8.
11. Chu KH, Chiang BL. Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity. Am J Respir Cell Mol Biol 2011; 46: 651-659.
12. Chen X, Jensen PE. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP31CD4 T cells. J Immunol 2007; 179: 2046-2050.
13. Morlacchi S, Soldani C, Viola A, Sarukhan A. Self-Antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion. Blood 2011; 118: 984-991.
14. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 2010; 1183: 38-57.
15. Fu CL, Chuang YH, Huang HY, Chiang BL. Induction of IL-10 producing CD41 T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells. Clin Exp Immunol 2008; 153: 258-268.
16. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD251CD41 Tr cells. Blood. 2005; 105: 1162-1169.
17. Bacchetta R, Gregori S, Roncarolo MG. CD41 regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 2005; 4: 491-496.
18. Ahangarani RR, Janssens W, VanderElst L, Carlier V, VandenDriessche T, ChuahMet al. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-Term IL-10-dependent antigen-specific unresponsiveness. J Immunol 2009; 183: 8232-8243.
19. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-717.
20. Reichardt P, Dornbach B, Gunzer M. The molecular makeup and function of regulatory and effector synapses. Immunol Rev 2007; 218: 165-177.
21. Fujio K, Okamura T, Yamamoto K. The family of IL-10-secreting CD41 T cells. Adv Immunol 2010; 105: 99-130.
22. Croft M, So T, Duan W, Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 2009; 229: 173-191.
23. Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann NY Acad Sci 2011; 1217: 45-59.
24. Chen X, Subleski JJ, Kopf H, Howard OM, Mannel DN, OppenheimJJ. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD41CD251FoxP31 T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol 2008; 180: 6467-6471.
25. Han Y, Guo Q, Zhang M, Chen Z, Cao X. CD691 CD41 CD252 T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 2009; 182: 111-120.
26. Weiss EM, Schmidt A, Vobis D, Garbi N, Lahl K, Mayer CT et al. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells. J Immunol 2011; 187: 1684-1691.
27. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z et al. CTLA-4 control over Foxp31 regulatory T cell function. Science 2008; 322: 271-275.
28. Ji HB, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004; 172: 5823-5827.
29. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024-1032.
30. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34: 566-578.
31. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 13: 108-116.
32. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF et al. In vitro generation of interleukin 10-producing regulatory CD41 T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-And Th2-inducing cytokines. J Exp Med 2002; 195: 603-616.
33. Noh G, Lee JH. Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res 2011; 3: 168-177.
34. Zhong X, Gao W, Degauque N, Bai C, Lu Y, Kenny J et al. Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells. Eur J Immunol 2007; 37: 2400-2404.
35. Wu K, Bi Y, Sun K, Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 2007; 4: 269-275.
36. Battaglia M, Gregori S, Bacchetta R, Roncarolo M. Tr1 cells: from discovery to their clinical application. Semin Immunol 2006; 18: 120-127.
37. Margry B, Wieland WH, van Kooten PJ, van Eden W, Broere F. Peritoneal cavity B-1a cells promote peripheral CD41 T-cell activation. Eur J Immunol 2013; 43: 2317-2326.
38. Labadi A, Balogh P. Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling. Int Immunol 2009; 21: 1047-1056.
39. Gao J, Ma X, Gu W, Fu M, An J, Xing Y et al. Novel functions of murine B1 cells: active phagocytic and microbicidal abilities. Eur J Immunol 2012; 42: 982-992.
40. Parra D, Rieger AM, Li J, Zhang YA, Randall LM, Hunter CA et al. Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD41 T cells. J Leukoc Biol 2012; 91: 525-536.
41. Hand TW, dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, Pepper M et al. Acute gastrointestinal infection induces long-lived microbiotaspecific T cell responses. Science 2012; 337: 1553-1556.